Restriction Genes for Retroviruses Influence the Risk of Multiple Sclerosis

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Nexø, Bjørn A ^a   Hansen, Bettina ^a   Nissen, Kari K ^a   Gundestrup, Lisa ^a   Terkelsen, Thorkild ^a   Villesen, Palle ^a   Bahrami, Shervin ^b   Petersen, Thor ^c   Pedersen, Finn S ^a   Laska, Magdalena J ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b SKAUvaccines ^*  (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

TRIPARTITE MOTIF PROTEIN 5;

APOBEC3 GENE; ARTICLE; BST2 GENE; CHROMOSOME 11; CHROMOSOME 19; CHROMOSOME 22; CONTROLLED STUDY; ENDOGENOUS RETROVIRUS; GENE; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; RESTRICTION GENE; RETROVIRUS; SINGLE NUCLEOTIDE POLYMORPHISM; TREX GENE; TRIM GENE; TRIM22 GENE; TRIM5 GENE;

CARRIER PROTEINS; CYTOSINE DEAMINASE; ENDOGENOUS RETROVIRUSES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MULTIPLE SCLEROSIS; REPRESSOR PROTEINS; RETROVIRIDAE;

EID: 84884188512     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074063     Document Type: Article

References (22)

1. Pincus T, Rowe WP, Lilly F, (1971) A major genetic locus affecting resistance to infection with murine leukemia viruses. II. Apparent identity to a major locus described for resistance to friend murine leukemia virus. J Exp Med 133:1234-1241.
2. Hilditch L, Matadeen R, Goldstone DC, Rosenthal PB, Taylor IA, et al. (2011) Ordered assembly of murine leukemia virus capsid protein on lipid nanotubes directs specific binding by the restriction factor, Fv1. Proc Natl Acad Sci U S A 108: 5771-5776. doi:10.1073/pnas.1100118108. PubMed: 21436027.
3. Rahm N, Telenti A, (2012) The role of tripartite motif family members in mediating susceptibility to HIV-1 infection. Curr Opin HIV. AIDS 7: 180-186.
4. Nakayama KK, Shioda T, (2010). Anti-retroviral activity of TRIM5 alpha. Rev Med Virol 20: 77-92.
5. Passerini LD, Keckesova Z, Towers GJ, (2006) Retroviral restriction factors Fv1 and TRIM5alpha act independently and can compete for incoming virus before reverse transcription. J Virol 80: 2100-2105. doi:10.1128/JVI.80.5.2100-2105.2006. PubMed: 16474118.
6. Di Pietro A, Kajaste-Rudnitski A, Oteiza A, Nicora L, Towers GJ, et al. (2013) TRIM22 Inhibits Influenza A Virus Infection by Targeting the Viral Nucleoprotein for Degradation. J Virol 87: 4523-4533. doi:10.1128/JVI.02548-12. PubMed: 23408607.
7. Arias JF, Koyama T, Kinomoto M, Tokunaga K, (2012) Retroelements versus APOBEC3 family members: No great escape from the magnificent seven. Front Microbiol 3: 275. PubMed: 22912627.
8. Imahashi M, Nakashima M, Iwatani Y, (2012) Antiviral Mechanism and Biochemical Basis of the Human APOBEC3 Family. Front Microbiol 3: 250. PubMed: 22787460.
9. Le Tortorec A, Willey S, Neil SJ, (2011) Antiviral inhibition of enveloped virus release by tetherin/BST-2: action and counteraction. Viruses 3: 520-540. doi:10.3390/v3050520. PubMed: 21994744.
10. Galão RP, Le Tortorec A, Pickering S, Kueck T, Neil SJ, (2012) Innate sensing of HIV-1 assembly by Tetherin induces NFκB-dependent proinflammatory responses. Cell Host Microbe 12: 633-644. doi:10.1016/j.chom.2012.10.007. PubMed: 23159053.
11. Ilinskaya A, Derse D, Hill S, Princler G, Heidecker G, (2013). Cell-cell transmission allows human T-lymphotropic virus 1 to circumvent tetherin restriction. Virology 436: 201-209.
12. Mazur DJ, Perrino FW, (1999) Identification and expression of the TREX1 and TREX2 cDNA sequences encoding mammalian. 3'-5' exonucleases. J Biol Chem 274: 19655-19656.
13. Chahwan C, Chahwan R, (2012) Aicardi-Goutieres syndrome: from patients to genes and beyond. Clin Genet 81: 413-420. doi:10.1111/j.1399-0004.2011.01825.x. PubMed: 22149989.
14. Nexø BA, Christensen T, Frederiksen J, Møller-Larsen A, Oturai AB, et al. (2011) The etiology of Multiple Sclerosis: Genetic evidence for the involvement of the human endogenous retrovirus HERV-Fc1. PLOS ONE 6: e16652. doi:10.1371/journal.pone.0016652. PubMed: 21311761.
15. Hansen B, Oturai AB, Harbo HF, Celius EG, Nissen KK, et al. (2011) Genetic association of multiple sclerosis with the endogenous retrovirus HERV-Fc1: Analysis of disease subtypes. PLOS ONE 6: e26438. doi:10.1371/journal.pone.0026438. PubMed: 22039488.
16. Laska MJ, Brudek T, Nissen KK, Christensen T, Møller Larsen A, et al. (2012) Expression of HERV-Fc1, a human endogenous retrovirus, is increase in patients with multiple sclerosis. J Virol 86: 3713-3722. doi:10.1128/JVI.06723-11. PubMed: 22278236.
17. Pertel T, Hausmann S, Morger D, Züger S, Guerra J, et al. (2011) TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 472: 361-365. doi:10.1038/nature09976. PubMed: 21512573.
18. Perron H, Garson JA, Bedin F, Beseme F, Paranhos-Baccala G, et al. (1997) Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The collaborative research group on multiple sclerosis. Proc Natl Acad Sci U S A 94: 7583-7588. doi:10.1073/pnas.94.14.7583. PubMed: 9207135.
19. Christensen T, Dissing Sørensen P, Riemann H, Hansen HJ, Møller-Larsen A, (1998) Expression of sequence variants of endogenous retrovirus rgh in particle form in multiple sclerosis. Lancet 352: 1033. doi:10.1016/S0140-6736(05)60075-X. PubMed: 9759750.
20. Maruszak H, Brew BJ, Giovannoni G, Gold J, (2011) Could antiretroviral drugs be effective in multiple sclerosis? A case report. Eur J Neurol 18: e110-e111. doi:10.1111/j.1468-1331.2011.03430.x. PubMed: 21834893.
21. Nexø BA, Pedersen L, Sørensen HT, Koch-Henriksen N, (2013) Treatment of HIV and risk of multiple sclerosis. Epidemiology 24: 331-332. doi:10.1097/EDE.0b013e318281e1cf. PubMed: 23377093.
22. Patsopoulos NA, et al. (2011) Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol 70: 897-912. doi:10.1002/ana.22609. PubMed: 22190364.